To figure out how MVP translocates to the cell surface, we treated Huh7 cells with some chemical inhibitors of cancer cell signaling pathways, and found that U0126 (ERK inhibitor) and rapamycin (mTOR inhibitor) obviously decreased cell surface expression of MVP (Supplementary Fig. 1b). Here, MTOR is linked to cancer.